Liquidia (NASDAQ:LQDA) CEO Sells $1,037,500.00 in Stock

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 25,000 shares of the company's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $41.50, for a total transaction of $1,037,500.00. Following the completion of the sale, the chief executive officer owned 1,298,095 shares in the company, valued at $53,870,942.50. This represents a 1.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

• MarketBeat Week in Review: 12/25 - 12/29

Roger Jeffs also recently made the following trade(s):

• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total transaction of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total transaction of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total transaction of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total transaction of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total transaction of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total transaction of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total transaction of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $1,003,000.00.

Liquidia Trading Up 6.5%

---

---

Shares of LQDA stock opened at $56.60 on Wednesday. The company has a 50 day moving average of $38.17 and a 200-day moving average of $35.29. The company has a quick ratio of 1.84, a current ratio of 2.01 and a debt-to-equity ratio of 2.97. Liquidia Corporation has a 12-month low of $11.85 and a 12-month high of $57.00. The firm has a market cap of $5.03 billion, a P/E ratio of 404.31 and a beta of 0.41.

• Liquidia: Court victory the awakening of an industry giant?

Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 81.61%. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. The company's revenue was up 4187.1% on a year-over-year basis. Sell-side analysts anticipate that Liquidia Corporation will post 2.14 earnings per share for the current year.

Institutional Trading of Liquidia

A number of hedge funds have recently made changes to their positions in the stock. Swiss National Bank lifted its holdings in shares of Liquidia by 1.3% during the 1st quarter. Swiss National Bank now owns 120,400 shares of the company's stock worth $4,544,000 after acquiring an additional 1,600 shares during the last quarter. Hanseatic Management Services Inc. bought a new stake in shares of Liquidia during the 1st quarter worth $772,000. Archer Investment Corp bought a new stake in shares of Liquidia during the 1st quarter worth $259,000. LGT Fund Management Co Ltd. bought a new stake in shares of Liquidia during the 1st quarter worth $4,161,000. Finally, Valmark Advisers Inc. lifted its holdings in shares of Liquidia by 10.2% during the 1st quarter. Valmark Advisers Inc. now owns 20,546 shares of the company's stock worth $775,000 after acquiring an additional 1,905 shares during the last quarter. 64.54% of the stock is owned by institutional investors.

More Liquidia News

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia delivered a major Q1 beat on both earnings and revenue, reinforcing confidence in its commercial momentum and profitability. Liquidia Corporation Reports First Quarter 2026 Financial Results
• Positive Sentiment: YUTREPIA sales continue to accelerate, with management targeting at least $1 billion in net revenue by 2027, which suggests a long runway for growth if launch momentum continues. Positive Sentiment
• Positive Sentiment: Needham and BTIG both raised price targets and maintained bullish ratings, signaling Wall Street sees more upside after the earnings release. Liquidia (NASDAQ:LQDA) Price Target Raised to $70.00 at Needham & Company LLC
• Neutral Sentiment: CEO Roger Jeffs sold 25,000 shares under a pre-arranged 10b5-1 plan; the transaction is small relative to his remaining stake, but it may still draw some investor attention. SEC filing
• Negative Sentiment: One recent note argued that YUTREPIA’s launch upside may be getting closer to a ceiling, suggesting the market could eventually question how much more share growth is available. Liquidia: Yutrepia's Launch Momentum Is Approaching A Ceiling (Rating Downgrade)

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on LQDA shares. BTIG Research raised their price target on shares of Liquidia from $50.00 to $59.00 and gave the stock a "buy" rating in a research note on Monday. Needham & Company LLC raised their price target on shares of Liquidia from $54.00 to $70.00 and gave the stock a "buy" rating in a research note on Monday. Wells Fargo & Company raised their price objective on shares of Liquidia from $51.00 to $62.00 and gave the stock an "overweight" rating in a report on Tuesday. Zacks Research raised shares of Liquidia from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 5th. Finally, Wall Street Zen raised shares of Liquidia from a "hold" rating to a "buy" rating in a report on Saturday, March 7th. Three investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the stock. According to MarketBeat, Liquidia has a consensus rating of "Moderate Buy" and a consensus target price of $49.33.

Read Our Latest Stock Analysis on LQDA

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Featured Articles

• Five stocks we like better than Liquidia
• Navy Catalyst Ignites Odysight’s Growth Engine
• AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
• Axon Surged After Earnings and Is Still Down Over 50% From Highs
• The Event That Could Redefine Apple’s Summer Rally

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].